Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study).

Yifei, Zhang,; Yanyun, Gu,; Huahui, Ren,; Shujie, Wang,; Huanzi, Zhong,; Xinjie, Zhao,; Jing, Ma,; Xuejiang, Gu,; Yaoming, Xue,; Shan, Huang,; Jialin, Yang,; Li, Chen,; Gang, Chen,; Shen, Qu,; Jun, Liang,; Li, Qin,; Qin, Huang,; Yongde, Peng,; Qi, Li,; Xiaolin, Wang,; Ping, Kong,; Guixue, Hou,; Mengyu, Gao,; Zhun, Shi,; Xuelin, Li,; Yixuan, Qiu,; Yuanqiang, Zou,; Huanming, Yang,; Jian, Wang,; Guowang, Xu,; Shenghan, Lai,; Junhua, Li,; Guang, Ning,; Weiqing, Wang,

doi:10.1038/s41467-020-18414-8

Public

Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study).

Published in Nature communications • Oct 6, 2020

Authors:

Zhang, Yifei

Gu, Yanyun

Ren, Huahui

Abstract

Human gut microbiome is a promising target for managing type 2 diabetes (T2D). Measures altering gut microbiota like oral intake of probiotics or berberine (BBR), a bacteriostatic agent, merit metabolic homoeostasis. We hence conducted a randomized, double-blind, placebo-controlled trial with newly ...

Subject

Berberine

Diabetes Mellitus

Type 2

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!